• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Cohesive bandages, CBN1104

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall Cohesive bandages, CBN1104 see related information
Date Initiated by Firm November 17, 2015
Date Posted January 30, 2016
Recall Status1 Terminated 3 on September 13, 2016
Recall Number Z-0734-2016
Recall Event ID 72910
Product Classification Tape and bandage, adhesive - Product Code KGX
Product MediChoice Cohesive Bandages, One (1) roll of cohesive bandage per bag, thirty-six (36) bags per case [all model numbers have equivalent packaging]
General Hospital Use.
Code Information Item No. Lot No. Expiration Date: CBN1104 15023H09A Jan-18, CBN1104 15033H09A Feb-18, CBN1104 15043H09A Mar-18, CBN1104 15053H09A Apr-18, CBN1104 15063H09A May-18, CBN1104 15073H09A Jun-18, CBN1104 15083H09A Jul-18, CBN1104 14113H09A Oct-17, CBN1104 14123H09A Nov-17, CBN1104 15013H09A Dec-17, CBN1104 14063H09A May-17, CBN1104 14083H09A Jul-17, CBN1104 14093H09A Aug-17, CBN1104 14053H09A Apr-17, CBN1104 14043H09A Mar-17, CBN1104 14013H09A Dec-16, CBN1104 13053H09A Apr-16, CBN1104 12113H09A Oct-15, CBN1104 13033H09A Feb-16, CBN1104 13083H09A Jul-16, CBN1104 13083H09A Jul-16, CBN1104 13103H09A Sep-16, CBN1104 13113H09A Oct-16, CBN1104 13123H09A Nov-16.
Recalling Firm/
Owens & Minor Distribution, Inc.
9120 Lockwood Blvd
Mechanicsville VA 23116-2015
For Additional Information Contact
Manufacturer Reason
for Recall
MediChoice sterile cohesive bandages imported and sold under a private brand by Owens & Minor were tested and found to have microbial contamination.
FDA Determined
Cause 2
Under Investigation by firm
Action The firms recall strategy is as follows : recall was initiated by the Owens & Minor Home Office Recall Officer. The Home Office Recall Officer e-mailed the following documents to the Distribution Center (DC) Recall Officer at each affected DC: 1. DC Recall Letter (specific instructions for the DCs), 2. Recall Inventory Report form (for the DCs to record the amount of affected product quarantined), 3. Customer Letter (specific instructions for the customers), 4. Recall Return Response Form (for the customers to report back the details of the quantity of affected product in their inventory), 5. Attachment 1 (a document that provides examples of the product labeling), 6. Recall Checklist (a checklist for the DCs listing the actions that need to be completed), and 7. Recall Combine Queries spreadsheet (listing customers and current on-hand inventory at the DCs). The DC Recall Officer at each DC forwarded the information to the DC Customer Service team. The DC Customer Service team notified each impacted customer via e-mail or letter based upon the customers recorded preference. Level to which the recall was initiated: The recall was initiated to the level of the customer (i.e., hospitals, clinics, surgery centers). Follow-up plans: A minimum of three (3) attempts are made to obtain an acknowledgment from the customer that they received the recall notification. An attempt to determine the status of non-responsive businesses will be made. If the non-responsive business is still viable, an attempt will be made to determine the employee responsible for management of recalls and the recall notice will be sent to that employee. If the business is no longer viable, the steps described below for out-of-business accounts will be followed. Sub-recall: No sub-recall is required. These products are supplied to User Facilities and not distributed to commercial sub-accounts. Plans for effective checks: 1. Check records to ensure that the initial recall not
Quantity in Commerce 96266
Distribution Nationwide Distribution.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.